Sign In
Buy RPRX
$58.43
-0.590 (-1.00%)
At Close: Jul 31, 2026
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:02am, Wednesday, 29'th Jul 2026
Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bank of New York Mellon Corp Reduces Stock Position in Royalty Pharma PLC $RPRX
04:07am, Thursday, 23'rd Jul 2026
Bank of New York Mellon Corp decreased its position in Royalty Pharma PLC (NASDAQ: RPRX) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Comm
Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from Neurimmune
07:05am, Wednesday, 22'nd Jul 2026
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a portion of Neurimmune's royalty interest in AstraZeneca's cliramitug for up to $425
Royalty Pharma PLC $RPRX Holdings Lowered by AlTi Global Inc.
03:13am, Tuesday, 21'st Jul 2026
AlTi Global Inc. trimmed its position in Royalty Pharma PLC (NASDAQ: RPRX) by 50.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The
Chicago Partners Investment Group LLC Purchases New Position in Royalty Pharma PLC $RPRX
04:11am, Sunday, 19'th Jul 2026
Chicago Partners Investment Group LLC purchased a new stake in Royalty Pharma PLC (NASDAQ: RPRX) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commissi
Royalty Pharma declares third quarter 2026 dividend
04:15pm, Friday, 17'th Jul 2026
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2026 of $0.235 per Class A ordin
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:01am, Friday, 17'th Jul 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026
04:15pm, Wednesday, 15'th Jul 2026
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the U.S.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Monday, 13'th Jul 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Royalty Pharma (RPRX) Could Beat Earnings Estimates Again
01:10pm, Friday, 10'th Jul 2026
Royalty Pharma (RPRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are You Looking for a Top Momentum Pick? Why Royalty Pharma (RPRX) is a Great Choice
01:01pm, Friday, 10'th Jul 2026
Does Royalty Pharma (RPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run?
10:16am, Friday, 10'th Jul 2026
Royalty Pharma (RPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
RPRX or ACAD: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 09'th Jul 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Royalty Pharma (RPRX) and Acadia Pharmaceuticals (ACAD). But which of these two companies is the bes
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
07:14am, Thursday, 11'th Jun 2026
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect
Royalty Pharma plc (RPRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
06:22pm, Tuesday, 09'th Jun 2026
Royalty Pharma plc (RPRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
